Evidence map›Paper›PMID 38785090›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024

FosA8-producing

Katerina Chudejova, Maria Sofia Caltagirone, Vittoria Mattioni Marchetti, Antonella Rezzani, Antonella Navarra, Ibrahim Bitar

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Fosfomycin-resistantJAC-antimicrobial resistance · 2025
    Article
  3. FosA3 emerging in clinical carbapenemase-producingFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katerina ChudejovaDepartment of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czechia.
Maria Sofia CaltagironeMicrobiology Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.
Vittoria Mattioni MarchettiScienze Clinico, Chirurgiche, Diagnostiche, Pediatriche Department, Microbiology Unit, University of Pavia, Pavia, Italy.
Antonella RezzaniMicrobiology Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.
Antonella NavarraMicrobiology Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.
Ibrahim BitarDepartment of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czechia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fosfomycin-resistant FosA8-producing

Indexed as

Anti-Bacterial AgentsEscherichia coliEscherichia coli Infectionsbeta-LactamasesDrug Resistance, BacterialFemaleFosfomycinHumansItalyMaleMicrobial Sensitivity TestsMultilocus Sequence TypingAnti-Bacterial Agentsbeta-LactamasesFosfomycinE. coli ST131FosA8FosfomycinFosfomycin resistance,

Identifiers

PMID38785090
PMCPMC11128740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.